Results 181 to 190 of about 1,991 (194)

Impact of the Myosin Modulator Mavacamten on Force Generation and Cross‐Bridge Behavior in a Murine Model of Hypercontractility

Journal of the American Heart Association, 2018
Ranganath Mamidi, Jiayang Li, Chang Yoon Doh   +2 more
exaly  

Stop Dreaming: Mavacamten REMS Data Are Here

Circulation: Heart Failure
Ahmad Masri, Neal K. Lakdawala
openaire   +2 more sources

Mavacamten/sotalol

Reactions Weekly
openaire   +1 more source

Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM

JACC: Cardiovascular Imaging
Milind Y Desai, Katherine Wolski, Jeffrey B Geske   +2 more
exaly  

Mavacamten (Camzyos) for obstructive hypertrophic cardiomyopathy.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source

Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten

Heart Rhythm
Matteo Castrichini, John Giudicessi
exaly  

Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center

Progress in Cardiovascular Diseases
Milind Y Desai, Zoran B Popovic
exaly  

Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy

Mayo Clinic Proceedings
John R, Giudicessi, Said, Alsidawi, Jeffrey B, Geske, Darrell B, Newman, Adelaide M, Arruda-Olson, J Martijn, Bos, Steve R, Ommen, Michael J, Ackerman   +7 more
openaire   +2 more sources

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Circulation
Milind Y Desai, Katherine Wolski, Anjali Tiku Owens   +2 more
exaly  

Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial

Circulation: Cardiovascular Imaging
Milind Y Desai, Jeffrey B Geske, Albree Tower-Rader   +2 more
exaly